Insider · CIK 0001387521
James R Meyers
Files at SGMOQ (SANGAMO THERAPEUTICS, INC), CTMX (CytomX Therapeutics, Inc.), VERA (Vera Therapeutics, Inc.). First filing -, latest -.
James R Meyers files SEC Form 4 as director at SGMOQ (SANGAMO THERAPEUTICS, INC), and also at CTMX (CytomX Therapeutics, Inc.), VERA (Vera Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James R Meyers has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | CTMX CytomX Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +59,000 | $0.00 | $0 | 59,000 | Jun 22, 2026 |
| May 21, 2026 | VERA Vera Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,084 | $0.00 | $0 | 17,084 | May 26, 2026 |
| Nov 25, 2025 | VERA Vera Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Nov 26, 2025 |
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 99,600 | Jun 16, 2025 |
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 11, 2025 | CTMX CytomX Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 13, 2025 |
Questions about James R Meyers
Answered from the filings on this page, as of the latest one.
Is James R Meyers buying or selling?
James R Meyers has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James R Meyers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James R Meyers has 0.
Where does James R Meyers file Form 4?
James R Meyers has filed Form 4 at SGMOQ (SANGAMO THERAPEUTICS, INC); CTMX (CytomX Therapeutics, Inc.); VERA (Vera Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.